| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.5M | +72.2% |
| SG&A Expense | $7.3M | -14.6% |
| Operating Income | -$22.8M | -30.0% |
| Interest Expense | $790K | +170.2% |
| Pre-tax Income | -$23.5M | -33.1% |
| Net Income | -$23.5M | -33.1% |
| EPS (Basic) | -$26.00 | -1566.7% |
| EPS (Diluted) | -$26.00 | +11.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52K | -99.0% |
| Current Assets | $579K | -92.6% |
| Total Assets | $3.5M | -69.4% |
| Current Liabilities | $10.2M | +45.8% |
| Total Liabilities | $10.4M | +37.7% |
| Stockholders' Equity | -$6.9M | -277.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.0M | +5.3% |
| Capital Expenditures | $224K | +46.1% |
| Investing Cash Flow | -$224K | -46.8% |
| Financing Cash Flow | $10.0M | +103.2% |
| Free Cash Flow | -$15.3M | +4.8% |